IDT Australia (ASX:IDT) Inventories, Inventories Adjustments: A$-0.13 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is IDT Australia Inventories, Inventories Adjustments?

IDT Australia ASX:IDT -2.13% Inventories, Inventories Adjustments is A$-0.13 Mil as of Jun. 2026. The stock has 5 warning signs investors should review.

IDT Australia's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2026 was A$-0.13 Mil.

IDT Australia's quarterly Inventories, Inventories Adjustments increased from Jun. 2025 (A$-0.19 Mil) to Dec. 2025 (A$0.00 Mil) but then declined from Dec. 2025 (A$0.00 Mil) to Jun. 2026 (A$-0.13 Mil).

IDT Australia's annual Inventories, Inventories Adjustments increased from Jun. 2024 (A$-0.21 Mil) to Jun. 2025 (A$-0.19 Mil) and increased from Jun. 2025 (A$-0.19 Mil) to Jun. 2026 (A$-0.13 Mil).

IDT Australia Inventories, Inventories Adjustments Historical Data

* Premium members only.

The historical data trend for IDT Australia's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDT Australia Inventories, Inventories Adjustments Chart

IDT Australia Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Inventories, Inventories Adjustments
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 -0.26 -0.21 -0.19 -0.13

IDT Australia Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 0.00 -0.19 0.00 -0.13

IDT Australia Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

What does a Inventories, Inventories Adjustments of A$-0.13 Mil mean?
IDT Australia (ASX:IDT) has a Inventories, Inventories Adjustments of A$-0.13 Mil as of Jun. 2026. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on IDT Australia and its competitors.
Is IDT Australia's Inventories, Inventories Adjustments too high?
IDT Australia's current Inventories, Inventories Adjustments is A$-0.13 Mil.
How does IDT Australia's Inventories, Inventories Adjustments compare to ZTS?
IDT Australia's Inventories, Inventories Adjustments of A$-0.13 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Inventories Adjustments for a Drug Manufacturers company?
A good Inventories, Inventories Adjustments depends on the Drug Manufacturers industry context. However, Inventories, Inventories Adjustments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Inventories Adjustments mean?
A high Inventories, Inventories Adjustments can signal that a stock is expensive relative to its fundamentals. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on IDT Australia and its competitors. IDT Australia's current Inventories, Inventories Adjustments is A$-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current Inventories, Inventories Adjustments is A$-0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Inventories Adjustments calculated?
Inventories, Inventories Adjustments is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current Inventories, Inventories Adjustments is A$-0.13 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IDT Australia Business Description

Address 45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.